Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06999434
PHASE1

Exploring the Utility of [18F]3F4AP for Demyelination Imaging

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

The overall objective is to obtain an assessment of the pharmacokinetics of \[18F\]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal radiculopathy (SR).

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

105

Start Date

2025-05-05

Completion Date

2030-05-05

Last Updated

2025-05-31

Healthy Volunteers

Yes

Interventions

DRUG

[ 18F]3F4AP

PET Scan #3

DRUG

[18F]MK6240

PET Scan #2

DRUG

[11C]PIB

PET Scan #1

Locations (1)

Yale University PET Center

New Haven, Connecticut, United States